Dr. med. Dr. rer. nat. Lena-Christin Conradi

 
Staff Status
unigoe
 

1-23 of 23
 
The bibliographical data in your publication list are complete
You can correct existing data in the blue highlighted fields.To do this, please click on the coloured field. It is not possible to delete data here.
Fields that are not marked in colour (e. g. the authors) can be edited using the input form. To do so, click on the in front of the respective publication.
The bibliographic data in your publication list may be incomplete. You can
  • add any missing data in the fields marked in red or
  • correct existing data in the blue highlighted fields.
To do this, please click on the coloured field. It is not possible to delete data here.
Fields that are not marked in colour (e. g. the authors) can be edited using the input form. To do so, click on the in front of the respective publication.
Check/Uncheck all
  • 2016 Conference Abstract
    ​ ​The prognostic role of the host immune response in rectal cancer patients treated with neoadjuvant chemoradiation.​
    Sprenger, T. ; Wirtz, R. M; Pektas, S.; Bohnenberger, H. ; Kauffels, A. ; Conradi, L.-C.   & Homayounfar, K.  et al.​ (2016)
    34(4) pp. 575​-575. ​Gastrointestinal Cancers Symposium​, San Francisco, CA.
    Alexandria​: Amer Soc Clinical Oncology. DOI: https://doi.org/10.1200/jco.2016.34.4_suppl.575 
    Details  DOI  WoS 
  • 2016 Conference Abstract
    ​ ​Repeated anti-CEA radioimmunotherapy (RIT) with 131I-Labetuzumab after complete resection of colorectal liver metastases - safety, feasibility and long-term efficacy results of a prospective phase-II-study​
    Homayounfar, K. ; Sahlmann, C.-O. ; Niessner, M. ; Dyczkowski, J.; Conradi, L.-C. ; Braulke, F.   & Meller, B.  et al.​ (2016)
    Oncology Research and Treatment39 
    Basel​: Karger.
    Details  WoS 
  • 2016 Conference Abstract
    ​ ​Neoadjuvant therapy in rectal cancer - challenges of biobanking tumor biopsies taken prior to treatment​
    Jo, P. ; Gusky, L.; Nietert, M. M. ; Kitz, J. ; Conradi, L.-C. ; Müller-Dornieden, A. & Schueler, P. et al.​ (2016)
    Oncology Research and Treatment39 
    Basel​: Karger.
    Details  WoS 
  • 2015 Conference Abstract
    ​ ​Heterogeneity of colorectal cancer liver metastasis - analysis of WNT pathway patterns via High-throughput and bioinformatics profiling​
    Bleckmann, A. ; Wachter, A. ; Conradi, L.-C. ; Wolff, A. ; Hoppenau, C.; Korf, U. & Schildhaus, H.-U.  et al.​ (2015)
    Oncology Research and Treatment38 
    Basel​: Karger.
    Details  WoS 
  • 2014 Conference Abstract
    ​ ​Effects of 5-FU dose monitoring under neoadjuvant radiochemotherapy for locally advanced rectal cancer​
    Quack, H.; Stanek, K.; Wolff, H. A. ; Dröge, L. H.; Binder, L.; Bleckmann, A.   & Nietert, M. M.  et al.​ (2014)
    Oncology Research and Treatment37 
    Basel​: Karger.
    Details  WoS 
  • 2014 Conference Abstract
    ​ ​SRC expression in locally advanced rectal cancer-before and after neoadjuvant chemoradiotherapy​
    Ruehlmann, F. ; Nietert, M. M. ; Sprenger, T. ; Wolff, H. A. ; Homayounfar, K. ; Ghadimi, M. B.   & Beißbarth, T.  et al.​ (2014)
    Oncology Research and Treatment37 
    Basel​: Karger.
    Details  WoS 
  • 2014 Conference Abstract
    ​ ​Residual rectal cancer after preoperative radiochemotherapy (ypT1-2): An indication for local excision instead of radical surgery?​
    Sprenger, T. ; Rothe, H.; Conradi, L.-C. ; Homayounfar, K. ; Beißbarth, T. ; Ghadimi, M. B.   & Liersch, T. ​ (2014)
    Journal of Clinical Oncology32(3) ​Gastrointestinal Cancers Symposium​, San Francisco, CA.
    Alexandria​: Amer Soc Clinical Oncology.
    Details  WoS 
  • 2014 Conference Abstract
    ​ ​Cytokinesis-block micronucleus cytome assay for in vivo and in vitro lymphocyte radiosensitivity in patients undergoing radiochemotherapy for locally advanced rectal cancer​
    Dröge, L. H.; Hennies, S.; Beißbarth, T. ; Lorenzen, S.; Conradi, L.-C. ; Quack, H. & Ghadimi, M. B.  et al.​ (2014)
    Strahlentherapie und Onkologie190 ​20th Annual Congress of the German-Society-for-Radiation-Oncology​, Dusseldorf, GERMANY.
    Munich​: Urban & Vogel.
    Details  WoS 
  • 2013 Conference Abstract
    ​ ​HER-2 and HER-3 expression in locally advanced rectal cancer and metachronous metastases: new targets for treatment approaches?​
    Conradi, L.-C. ; Styczen, H.; Sprenger, T. ; Wolff, H. A. ; Middel, P.; Nagelmeier, I. & Rüschoff, J. R.  et al.​ (2013)
    Onkologie36 
    Basel​: Karger.
    Details  WoS 
  • 2013 Conference Abstract
    ​ ​5-FU dose monitoring under neoadjuvant radiochemotherapy and adjuvant chemotherapy for locally advanced rectal cancer​
    Conradi, L.-C. ; Quack, H.; Sprenger, T. ; Wolff, H. A. ; Binder, L.; Ghadimi, M. B.   & Homayounfar, K.  et al.​ (2013)
    Onkologie36 
    Basel​: Karger.
    Details  WoS 
  • 2013 Conference Abstract
    ​ ​Gender influences acute Toxicity during Chemoradiotherapy in Patients with Rectal cancer: Long-term results of the CAO/ARO/AIO 94 Trial​
    Wolff, H. A. ; Conradi, L.-C. ; Beißbarth, T. ; Leha, A. ; Hohenberger, W.; Merkel, S. & Fietkau, R. et al.​ (2013)
    Strahlentherapie und Onkologie189 ​19th Annual Congress of the German-Society-for-Radiation-Oncology​, Berlin, GERMANY.
    Munich​: Urban & Vogel.
    Details  WoS 
  • 2013 Conference Abstract
    ​ ​Context of persistent DNA Damage (Micronuclei) and Late Side Effects after Multimodal Radiochemotherapy in Patients with locally advanced Rectal cancer​
    Droege, L. H.; Hennies, S.; Beißbarth, T. ; Conradi, L.-C. ; Helms, C.; Hess, C. F.   & Rave-Fränk, M.  et al.​ (2013)
    Strahlentherapie und Onkologie189 ​19th Annual Congress of the German-Society-for-Radiation-Oncology​, Berlin, GERMANY.
    Munich​: Urban & Vogel.
    Details  WoS 
  • 2013 Conference Abstract
    ​ ​Association of CD133 expression levels with the k-ras mutation status in rectal cancers before and after preoperative radiochemotherapy​
    Sprenger, T. ; Gaedcke, J. ; Conradi, L.-C. ; Jo, P. ; Jung, K. ; Beißbarth, T.   & Homayounfar, K.  et al.​ (2013)
    Journal of Clinical Oncology31(4) ​Gastrointestinal Cancers Symposium of the American-Society-of-Clinical-Oncology (ASCO)​, San Francisco, CA.
    Alexandria​: Amer Soc Clinical Oncology.
    Details  WoS 
  • 2012 Conference Abstract
    ​ ​Clinical significance and prognostic impact of CD133 expression in rectal cancer treated with preoperative radiochemotherapy​
    Sprenger, T. ; Conradi, L.-C. ; Beißbarth, T. ; Homayounfar, K. ; Rüschoff, J. R. ; Roedel, C. & Ghadimi, M. B.  et al.​ (2012)
    Journal of Clinical Oncology30(15) ​48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)​, Chicago, IL.
    Alexandria​: Amer Soc Clinical Oncology.
    Details  WoS 
  • 2012 Conference Abstract
    ​ ​Cetuximab, capecitabine, oxaliplatin, and radiotherapy as preoperative triple treatment for rectal cancer (CET-CAPOX-RT-Phase-I/II Study): Influence on long-term survival and relevance of biomarkers​
    Liersch, T. ; Conradi, L.-C. ; Sprenger, T. ; Middel, P.; Suelberg, H.; Roedel, F. & Rüschoff, J. R.  et al.​ (2012)
    Journal of Clinical Oncology30(15) ​48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)​, Chicago, IL.
    Alexandria​: Amer Soc Clinical Oncology.
    Details  WoS 
  • 2012 Conference Abstract
    ​ ​HER-2 in locally advanced rectal cancer (cUICC II/III): positivity rate and prognostic value​
    Conradi, L.-C. ; Styczen, H.; Sprenger, T. ; Wolff, H. A. ; Homayounfar, K. ; Becker, H. & Ghadimi, M. B.  et al.​ (2012)
    British Journal of Surgery99 ​99th Annual Congress of the Swiss-Society-of-Surgery​, Davos, SWITZERLAND.
    Malden​: Wiley-blackwell.
    Details  WoS 
  • 2012 Conference Abstract
    ​ ​HER2 status in locally advanced rectal cancer and metachronous metastases: Opportunity for a new therapeutic approach?​
    Conradi, L.-C. ; Styczen, H.; Sprenger, T. ; Homayounfar, K. ; Wolff, H. A. ; Bleckmann, A.   & Rüschoff, J. R.  et al.​ (2012)
    Journal of Clinical Oncology30(15) , Chicago, IL.
    Alexandria​: Amer Soc Clinical Oncology.
    Details  WoS 
  • 2011 Conference Abstract
    ​ ​Thymidylate Synthase as Biomarker in Rectal Cancer Patients After 5-FU-based Radiochemotherapy - Evaluation of the Prognostic Capacity in Pre-treatment Biopsies and Resected Adenocarcinoma​
    Conradi, L.-C. ; Bleckmann, A. ; Sprenger, T. ; Schirmer, M. A. ; Homayounfar, K. ; Wolff, H. A.   & Becker, H. et al.​ (2011)
    European Journal of Cancer47 ​European Multidisciplinary Cancer Congress on Integrating Basic and Translational Science, Surgery, Radiotherapy, Medical oncology, Advocacy and Care​, Stockholm, SWEDEN.
    Oxford​: Elsevier Sci Ltd.
    Details  WoS 
  • 2011 Conference Abstract
    ​ ​Biomarker study in rectal cancer patients after 5FU-based radiochemotherapy: Evaluation of the prognostic capacity of thymidylate synthase in pretreatment biopsies and resected adenocarcinoma.​
    Conradi, L.-C. ; Bleckmann, A. ; Schirmer, M. A. ; Sprenger, T. ; Homayounfar, K. ; Wolff, H. A.   & Becker, H. et al.​ (2011)
    Journal of Clinical Oncology29(4) 
    Alexandria​: Amer Soc Clinical Oncology.
    Details  PMID  PMC  WoS 
  • 2011 Conference Abstract
    ​ ​Association of survivin expression following neoadjuvant radiochemotherapy in rectal cancer with distant metastases and survival.​
    Sprenger, T. ; Roedel, F.; Beißbarth, T. ; Conradi, L.-C. ; Homayounfar, K. ; Ghadimi, M. B.   & Yildrim, M. et al.​ (2011)
    Journal of Clinical Oncology29(4) 
    Alexandria​: Amer Soc Clinical Oncology.
    Details  PMID  PMC  WoS 
  • 2011 Conference Abstract
    ​ ​Survivin Expression in Rectal Cancer During Preoperative Radiochemotherapy and Its Impact on Metastasis and Patients' Survival​
    Sprenger, T. ; Roedel, F.; Beißbarth, T. ; Conradi, L.-C. ; Yildirim, M.; Ghadimi, M. B.   & Becker, H. et al.​ (2011)
    European Journal of Cancer47 ​European Multidisciplinary Cancer Congress on Integrating Basic and Translational Science, Surgery, Radiotherapy, Medical oncology, Advocacy and Care​, Stockholm, SWEDEN.
    Oxford​: Elsevier Sci Ltd.
    Details  WoS 
  • 2011 Conference Abstract
    ​ ​TGFB1 Pro25 allele as a risk marker for higher-grade acute Organ toxicity (CTC >= Grad2) during neoadjuvant Chemoradiotherapy in patients with locally advanced Rectal cancer (UICC Stage II/III)​
    Christiansen, H.; Schirmer, M. A. ; Mergler, C. P. N.; Rave-Fränk, M. ; Hennies, S.; Gaedcke, J.   & Conradi, L.-C.  et al.​ (2011)
    Strahlentherapie und Onkologie187 , Wiesbaden, GERMANY.
    Munich​: Urban & Vogel.
    Details  WoS 
  • 2011 Conference Abstract
    ​ ​A lack of down-regulation of survivin after neoadjuvant Chemoradiotherapy for Rectal cancer with distant metastasis and Reduced survival rate linked​
    Roedel, F.; Sprenger, T. ; Beißbarth, T. ; Conradi, L.-C. ; Rothe, H.; Homayonfaur, K. & Wolff, H. A.  et al.​ (2011)
    Strahlentherapie und Onkologie187 ​17th Annual Meeting of the German-Society-for-Radiation-Oncology​, Wiesbaden, GERMANY.
    Munich​: Urban & Vogel.
    Details  WoS 

Publication List

Type

Date issued

Author

Peer-Reviewed

Language

Fulltext

Options

Citation Style

https://publications.goettingen-research-online.de URI: /cris/rp/rp19107
ID: 0000000
PREF: default TOKEN:

0

Sort

Issue Date
Title

Embed

JavaScript
Link

Export

Activate Export Mode
Deactivate Export Mode

Select some or all items (max. 800 for CSV/Excel) from the publications list, then choose an export format below.